Department of Thoracic, Cardiac and Vascular Surgery, University Hospital of Tübingen, Germany.
Clin Appl Thromb Hemost. 2011 Aug;17(4):340-5. doi: 10.1177/1076029610364519. Epub 2010 May 11.
Thoracic mobile aortic mural thrombus (TAMT) of the aortic arch is a rare condition. We report 3 cases of symptomatic TAMT treated with systemic alteplase (tissue plasminogen activator [t-PA]) thrombolysis. The first patient was symptomatic with repetitive thromboembolism to the left brachial artery. She was treated with repetitive thrombolysis after surgical embolectomy of the brachial artery. The second patient was symptomatic with splenic infarction and mesenteric ischemia. She was treated with a single cycle of systemic thrombolysis followed by ileocoecal resection. The third patient presented with a TAMT obstructing the left common carotid artery, causing ischemic stroke. After systemic thrombolysis, a reduction in thrombus size was documented; however, the patient died later, of acute heart failure, during the clinical course. On follow-up 6 months after the incidences, the 2 surviving patients were in good condition and free of thromboembolic events. We show that systemic thrombolytic therapy can be performed successfully in patients with TAMT.
胸主动脉壁移动性血栓(TAMT)是一种罕见的主动脉弓疾病。我们报告了 3 例症状性 TAMT 患者,他们接受了全身组织型纤溶酶原激活剂(t-PA)溶栓治疗。第 1 例患者出现左肱动脉反复血栓栓塞的症状,在肱动脉手术取栓后接受了重复溶栓治疗。第 2 例患者出现脾梗死和肠系膜缺血的症状,接受了单次全身溶栓治疗,随后进行回盲部切除术。第 3 例患者表现为 TAMT 阻塞左侧颈总动脉,导致缺血性脑卒中。全身溶栓后,血栓大小有所减少;然而,患者在临床过程中因急性心力衰竭死亡。在发病后 6 个月的随访中,2 例存活患者状况良好,无血栓栓塞事件。我们表明,全身溶栓治疗可成功用于 TAMT 患者。